The 20 Best Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Doctors Near Me in Ann Arbor, MI
Find the Top Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Experts and Specialists
U Of M Radiology Nuclear Medicine
Richard Brown is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Brown is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Neuroendocrine Tumor, Mantle Cell Lymphoma (MCL), and Melorheostosis. Dr. Brown is board certified in Diagnostic Radiology, Nuclear Medicine, and Nuclear Radiology.
U Of M Radiology
Dr. Srinivasan went to medical school in Chennai, India and pursued radiology residency at the All India Institute Medical Sciences in New Delhi. Subsequently, he did a Neuroradiology fellowship at the University of Ottawa in Canada and then joined as faculty at the University of Michigan in Ann Arbor, USA. He is presently Director of the Neuroradiology division and Associate Professor of Radiology at the University of Michigan. He received the RSNA research scholar award from 2008-2010 for his project titled ‘Creation of prediction model for response to chemoradiation in head and neck squamous cell carcinoma’. He has published over 60 papers, written 8 book chapters and presented over 90 scientific or educational presentations at national and international conferences. He is a frequent speaker at national radiology and neuroradiology conferences in the US including the American Roentgen Ray Society and the American society of Head and Neck Radiology. He presently serves on the editorial board on the Head and neck section of two premier radiology journals “Radiology” and “European Radiology”. Dr. Srinivasan is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Stroke, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Synovial Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Thrombectomy.
U Of M Radiology
Gaurang Shah is a Radiologist and a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Stroke, Sciatica, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Relapsing Multiple Sclerosis (RMS). Dr. Shah is board certified in Diagnostic Radiology and Neuroradiology.
U Of M Cardiology
Dr. Yamada has been practicing medicine and cardiology for over 20 years. She has expertise in echocardiography which has allowed her to better understand, diagnose and treat cardiac disease. Her clinical and research interests include: cardiology oncology and the relationship between cancer treatment and heart disease; the role of echocardiography in understanding different cardiac pathologies and treatments; mitral valve disease; atrial fibrillation and general cardiology. Dr. Yamada launched the Cardio-Oncology clinic at the UMHS Cardiovascular Center in 2011, after a period of training at the MD Anderson Cancer Center. In this clinic, she evaluates patients who have cancer and are either at risk, or have developed cardiac disease as a complication of cancer treatment. Her goal in this clinic is to prevent, early diagnose and treat cardiac toxicity from cancer treatment, and to optimize underlying heart condition prior to cancer therapy. Dr. Yamada is also interested in helping childhood cancer survivors prevent heart complications from cancer treatment. Dr. Yamada is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Hypertension, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Arrhythmias, and Doxorubicin-Induced Cardiomyopathy. Dr. Yamada is board certified in Cardiovascular Disease.
U Of M Radiology
Anil Attili is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Attili is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Synovial Sarcoma, Adrenal Cancer, Lung Nodules, Rhabdomyosarcoma Embryonal, and Cardiac Ablation.
Rogel Cancer Center
The T-cell lymphomas are a heterogeneous and poorly understood group of non-Hodgkin’s lymphomas. The most common T-cell lymphoma in the United States includes a heterogeneous mix of lymphomas that lack distinguishing characteristics and, until recently, remained clinically and molecularly “unspecified”. Improved understanding of T-cell lymphoma pathogenesis and the development of novel therapeutic strategies will be needed to address this challenge and improve outcomes for patients afflicted with these aggressive lymphomas. My group made the landmark discovery that the most common T-cell lymphoma in North America is comprised of two molecularly and clinically distinct subsets. This finding has significant implications for the classification and treatment of these lymphomas. We have also demonstrated that malignant T cells remain dependent upon antigen-presenting cells within the tumor microenvironment and are developing novel therapeutic strategies targeting these cells. Many fundamental questions, including the “cell of origin”, the role of antigen-, costimulatory-, and cytokine-receptor signaling, and the contribution of myeloid-derived antigen-presenting cells in disease pathogenesis remain obscure. My laboratory uses complementary mouse models and primary T-cell lymphoma specimens (in ex vivo and patient-derived xenograft studies) to address these fundamental and clinically relevant questions. We are poised to clinically translate our laboratory-based findings into novel therapeutic strategies that we hope will improve outcomes for patients afflicted with these aggressive lymphomas. I enjoy working with a multidisciplinary team of enthusiastic collaborators who share this common goal. Dr. Wilcox is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is board certified in Internal Medicine, Hematology, and Medical Oncology.
U Of M Pathology
Dr. Lauren Smith received her undergraduate degree at the University of Michigan Honors College with highest distinction in 1992. She spent four years working in a neurogenetics laboratory at the University of San Francisco with Dr. Nelson Freimer. For the next two years she worked as a manuscript editor for Dr. Donald Klein, a psychiatrist, at Columbia University. In 1998, she began medical school at the University of Michigan. She was awarded AOA in her junior year and was president of the UM AOA Chapter the following year. She completed her residency in anatomic/clinical pathology and fellowship in hematopathology from 2002-2007. In July, 2007 she began her faculty career as an Assistant Professor at the University of Michigan and was promoted to Associate Professor in 2013. She was appointed Fellowship Director in 2013. She was appointed the Director of the Ethics Path of Excellence in the University of Michigan Medical School in 2013. She became the permanent Director of the Hematopathology Section in 2016. In addition, she serves as a Hospital Ethicist at UMHS. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 29 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, T-Cell Lymphoma, Peripheral T-Cell Lymphoma, and Angioimmunoblastic T-cell Lymphoma.
University Hospital
Benjamin Viglianti is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 17 years. Dr. Viglianti is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Osteopenia, Melorheostosis with Osteopoikilosis, and Melorheostosis. Dr. Viglianti is board certified in Diagnostic Radiology and Nuclear Medicine.
Frankel Cardiovascular Center
Mark Norris is a Pediatrics specialist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Norris is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 53 other conditions, according to our data. His clinical expertise encompasses Congenital Heart Disease (CHD), Tetralogy of Fallot, Double Outlet Left Ventricle, and Truncus Arteriosus.
Frankel Cardiovascular Center
William Armstrong is a Cardiologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Armstrong is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Aortic Valve Stenosis, Cardiac Ablation, and Pacemaker Implantation. Dr. Armstrong is board certified in Internal Medicine and Cardiovascular Disease.
C. S. Mott Children's Hospital
Thor Thorsson is a Pediatrics specialist and a Pediatric Cardiologist practicing medicine in Ann Arbor, Michigan. Dr. Thorsson is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 107 other conditions, according to our data. His clinical expertise encompasses Tetralogy of Fallot, Hypoplastic Left Heart Syndrome (HLHS), Mitral Atresia, and Isthmian Coarctation. Dr. Thorsson is board certified in Pediatric Cardiology.
C. S. Mott Children's Hospital
Heang Lim is a Pediatrics specialist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Lim is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Hypoplastic Left Heart Syndrome (HLHS), Mitral Atresia, Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, and Heart Transplant. Dr. Lim is board certified in Pediatrics and Pediatric Cardiology.
University Hospital
Molly Roseland is a Radiologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Roseland is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia. Dr. Roseland is board certified in Diagnostic Radiology and Nuclear Medicine.
Rogel Cancer Center
Mishal Mendiratta is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Mendiratta is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Liver Cancer, Fibrolamellar Carcinoma, Visceromegaly, and Cholangiocarcinoma (Bile Duct Cancer).
U Of M Radiology
Gary Luker is a Radiologist and a Pediatric Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Luker is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Myeloproliferative Neoplasms (MPN), Tracheoesophageal Fistula, Posterior Urethral Valves, Chondrodystrophy, and Hepato-Pancreato-Biliary Surgery. Dr. Luker is board certified in Diagnostic Radiology and Pediatric Radiology.
C. S. Mott Children's Hospital
Rama Rao is a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Chondrosarcoma, Hereditary Neuroblastoma, Neuroblastoma, and Bone Marrow Aspiration. Dr. Rao is board certified in Pediatric Hematology-Oncology.
C. S. Mott Children's Hospital
Attaphol Pawarode is a Hematologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Pawarode is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.
Rogel Cancer Center
Dr. Karimi is an Clinical Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Michigan. Dr. Karimi received her undergraduate degree from Johns Hopkins University, her medical degree from the University of Pennsylvania School of Medicine and went on to complete her internal medicine residency and chief residency at the University of Chicago. She completed her Hematology & Oncology fellowship at Stanford University before joining the lymphoma group at the University of Michigan Rogel Cancer Center.Her research focus is on conducting clinical trials in B cell lymphomas including diffuse large B cell lymphoma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, Hodgkin's lymphoma and CLL/SLL. Dr. Karimi is a member of the Non-Hodgkin Lymphoma Guidelines panel for the National Comprehensive Cancer Center Network (NCCN).Dr. Karimi finds joy in connecting with patients and families and is honored to be a part of their care team in their cancer journey. She has personal experience knowing how challenging it can be to navigate the decisions and treatments of indolent and aggressive lymphomas. Her goal is to provide meticulous and compassionate patient care while incorporating the most up to date understanding of the disease and latest advances in treatments to each patient's case.Outside of the hospital, Dr. Karimi enjoys cooking, yoga, and hiking in the national parks across America. Languages spoken: English, Spanish, Urdu, Gujarati. Dr. Karimi is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration. Dr. Karimi is board certified in Internal Medicine, Hematology, and Medical Oncology.
University Hospital
Kirk Frey is a Neurologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Frey is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Neuroendocrine Tumor, Osteopenia, and Hormone Replacement Therapy (HRT).
Rogel Cancer Center
Scott Gitlin is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Gitlin is rated as an Advanced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Hemangioma Thrombocytopenia Syndrome.
Last Updated: 04/28/2026


















